Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @AiCuris
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @AiCuris
-
Prikvačeni tweet
Why does it take so long to develop a drug? -
@AiCuris gives the answer to this question in a German TV documentary@GalileoLIVE: https://bit.ly/3b9QNyP pic.twitter.com/58HwXu5MzI
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Just in time with the WHO World Antibiotic Awareness Week
#WAAW2019, AiCuris reaffirmed its commitment to tackle one of the most scaring threats of the 21st century – antimicrobial resistant bacteria - at a BIO-Europe AMR panel. https://bit.ly/2NUyJ26 ; https://bit.ly/35osw4E pic.twitter.com/sWq5p3mc0F
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AiCuris GmbH proslijedio/la je Tweet
German newspaper
@handelsblatt writes about the challenges of companies active in#AMR citing@AllianceBEAM members@Bioversys@AiCurishttp://www.handelsblatt.com/technik/medizin/pharmaindustrie-biotech-unternehmen-treiben-den-kampf-gegen-bakterien-voran/25137894.html …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AiCuris GmbH proslijedio/la je Tweet
.
@BIODeutschland Vorstand Holger Zimmermann diskutiert auf#bioeurope zum Thema Antibiotika@AiCurispic.twitter.com/fpYiJYWvbg
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
@AiCuris Anti-infective Cures GmbH today provided a strategic update, outlining its recent achievements and plans for future growth - https://bit.ly/2NJ8jk1 pic.twitter.com/q6pGPzWxOB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AiCuris GmbH proslijedio/la je Tweet
Great panel discussion with Marc Gitzinger
@Bioversys@AllianceBEAM and@anand_bugworks about#AMR financing and the new impact investment fund@WHO@EIB at#WorldAMRCongress.pic.twitter.com/YVXgI5UZ8o
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
@AiCuris to attend#BIOEurope® and participate in AMR panel discussing the high medical need for novel antibiotics against the backdrop of challenging economic perspectives. Interested in meeting the management? Please follow the link for more info - https://bit.ly/2pKU3hn pic.twitter.com/NVflMErVg5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thanks
@MCServicesAG ! It‘s a honor for us to be awarded as Wuppertal‘s „Company of the year“. We‘re looking forward to investing further in this city.https://twitter.com/MCServicesAG/status/1182581468683476993 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you Bernward Garthoff for all your efforts for the Biotech industry in NRW!https://twitter.com/BIONRW/status/1182666427599347714 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AiCuris, being awarded with the "Wuppertaler Wirtschaftspreis” as “Company of the year”. https://bit.ly/2IEsrRq pic.twitter.com/r063SvgUOw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NDR reports on the growing threat of multidrug-resistant germs, missing effective antibiotics and pharmaceutical companies withdrawing from the development of new active ingredients. But this is not true for AiCuris. Read full statement (German): https://bit.ly/2lM7hIu https://twitter.com/ChBaars/status/1172203985073332226 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AiCuris GmbH proslijedio/la je Tweet
NDR reports on the growing threat of multidrug-resistant germs, missing effective antibiotics and pharmaceutical companies withdrawing from the development of new active ingredients. But this is not true for AiCuris. Read full statement (German): https://bit.ly/2lM7hIu pic.twitter.com/yjWLO9EopT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
NDR reports on the growing threat of multidrug-resistant germs, missing effective antibiotics and pharmaceutical companies withdrawing from the development of new active ingredients. But this is not true for AiCuris. Read full statement (German): https://bit.ly/2lM7hIu pic.twitter.com/yjWLO9EopT
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congrats to Prof. Rübsamen-Schaeff, Dr. Zimmermann and our entire scientific team. It's a great honor that
#Letermovir is now part of the biggest science museum of the world.https://twitter.com/MCServicesAG/status/1172044926458220545 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As winners of the German Future Prize 2018, Prof. Dr. Rübsamen-Schaeff and Dr. Zimmermann unveiled a module of AiCuris Letermovir project as part of the German Future Prize exhibition at the Deutsches Museum in Munich. - https://bit.ly/2ktJoVP pic.twitter.com/qBN1kXIhz2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Sad news! R.I.P. Johanhttps://twitter.com/COMBACTE/status/1152134676255072257 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It has been a pleasure to host our partners from
@LysandoAG to our kick-off meeting. Committed to fight#AMR by combining Lysando's Artilysin technology with@AiCuris' experience in bringing drugs to the market. https://twitter.com/AiCuris/status/1150716226680840193/photo/1pic.twitter.com/2yr5JYQz6w pic.twitter.com/gBL1zJ8kLY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What a fantastic news! A giant step on your way! Congrats!https://twitter.com/BioNTech_Group/status/1148521810281078784 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
AiCuris GmbH proslijedio/la je Tweet
BioNTech Raises $325m in Upsized Series B Financing to Advance Individualized Immuno-Oncology Pipeline https://biontech.de/2019/07/09/biontech-raises-usd-325-million-in-an-upsized-series-b-financing-to-further-advance-individualized-immuno-oncology-pipeline/ …
@BioNTech_GroupHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Congrats to our friends and colleagues at
@BioNTech_Group ! Great achievement!https://twitter.com/transkriptde/status/1148516661517070336 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.